Literature DB >> 23388018

Peripheral mechanisms in irritable bowel syndrome.

Zain Kassam, Stephen M Collins, Paul Moayyedi.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23388018     DOI: 10.1056/NEJMc1214185

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.

Authors:  Akihiro Shimozato; Makoto Sasaki; Naotaka Ogasawara; Yasushi Funaki; Masahide Ebi; Chiho Goto; Satoshi Koikeda; Takashi Joh; Kunio Kasugai
Journal:  United European Gastroenterol J       Date:  2017-01-31       Impact factor: 4.623

2.  Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.

Authors:  Zipeng Gong; Qing Yang; Yajie Wang; Xiaogang Weng; Yujie Li; Yu Dong; Xiaoxin Zhu; Ying Chen
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

3.  Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.

Authors:  Wen-Xue Zhang; Yu Zhang; Geng Qin; Kai-Min Li; Wei Wei; Su-Yun Li; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2019-11-21       Impact factor: 5.742

4.  Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.

Authors:  Yan Wang; Yong-Quan Huang; Shui-Lian Zhu; Chang-Rong Zhang; Xin-Lin Chen; Qiu-Ke Hou; Feng-Bin Liu
Journal:  Trials       Date:  2020-11-03       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.